OCX - Oncocyte Corp

QQQ $ 429.07 $ 5.38 (1.28 %)

DIA $ 382.31 $ 3.34 (0.88 %)

SPY $ 505.01 $ 4.68 (0.94 %)

TLT $ 88.87 $ 0.38 (0.43 %)

GLD $ 213.12 $ -0.66 (-0.31 %)

Previous Close

$ 2.7794

Open

$ 2.56

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.56 - $ 2.74

52 Week Range

$ 2.08 - $ 5.88

Volume

51,822

Average Volume

Market Cap

21.27M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	04-16-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	04-12-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-12-2022	03-31-2022	10-Q
9	03-11-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-11-2021	06-30-2021	10-Q
12	05-17-2021	03-31-2021	10-Q
13	03-19-2021	12-31-2020	10-K
14	11-12-2020	09-30-2020	10-Q
15	07-29-2020	06-30-2020	10-Q
16	05-12-2020	03-31-2020	10-Q
17	03-26-2020	12-31-2019	10-K
18	11-14-2019	09-30-2019	10-Q
19	08-14-2019	06-30-2019	10-Q
20	05-14-2019	03-31-2019	10-Q
21	04-01-2019	12-31-2018	10-K
22	11-13-2018	09-30-2018	10-Q
23	08-14-2018	06-30-2018	10-Q
24	05-15-2018	03-31-2018	10-Q
25	04-02-2018	12-31-2017	10-K
26	11-14-2017	09-30-2017	10-Q
27	08-14-2017	06-30-2017	10-Q
28	04-28-2017	03-31-2017	10-Q
29	02-27-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-11-2016	06-30-2016	10-Q
32	05-16-2016	03-31-2016	10-Q
33	03-30-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Maintains Buy on OncoCyte, Raises ...
04/24/2024 18:40:21

Needham analyst Mike Matson maintains OncoCyte (NASDAQ:OCX) with a Buy and raises the price target from $3.6 to $4.25.

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 12:06:32

Bio-Rad Laboratories Inc Reports 8.99% Pas...
04/22/2024 17:35:46

- SEC Filing

Stephens & Co. Reiterates Equal-Weight on ...
04/17/2024 14:16:03

Stephens & Co. analyst Mason Carrico reiterates OncoCyte (NASDAQ:OCX) with a Equal-Weight and maintains $4 price target.

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

Benchmark Reiterates Speculative Buy on On...
04/15/2024 15:09:08

Benchmark analyst Bruce Jackson reiterates OncoCyte (NASDAQ:OCX) with a Speculative Buy and maintains $5 price target.

why-medical-properties-trust-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Why Medical Properties Trust Shares Are Tr...
04/15/2024 09:45:11

Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced th...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/12/2024 20:31:04

Oncocyte shares are trading higher after t...
04/12/2024 13:22:06

top-3-health-care-stocks-that-may-collapse-in-q2

Top 3 Health Care Stocks That May Collapse...
04/12/2024 12:34:00

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum a...

Earnings Scheduled For April 12, 2024
04/12/2024 11:17:58

Companies Reporting Before The Bell • Progressive (NYSE:PGR) is projected to report quarterly earnings at $3.17 per share on r...

OncoCyte Q4 EPS $(2.18) Misses $(1.14) Est...
04/12/2024 10:07:09

OncoCyte (NASDAQ:OCX) reported quarterly losses of $(2.18) per share which missed the analyst consensus estimate of $(1.14) by ...

why-nextplat-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket

Why NextPlat Shares Are Trading Higher By ...
04/12/2024 09:32:49

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023...

Reported Earlier, Oncocyte Prices $15.8M P...
04/12/2024 06:48:46

Oncocyte Corporation, a precision diagnostics company, today announced that it has entered into definitive securities purchase ...

Oncocyte Announces Partnership Agreement W...
04/11/2024 21:32:54

The new product is expected to launch in Q2 2024 to a select group of academic transplant centers in the US and EU and more bro...

Oncocyte Begins FDA Single-Site Process Fo...
12/06/2023 13:01:52

This move positions Oncocyte within the recent proposed rule from the FDA that seeks to oversight LDTs and puts its lab-develop...

Piper Sandler Maintains Neutral on OncoCyt...
11/13/2023 21:18:55

Piper Sandler analyst David Westenberg maintains OncoCyte (NASDAQ:OCX) with a Neutral and lowers the price target from $3.5 ...

Why AMC Entertainment Shares Are Trading L...
11/09/2023 18:13:05

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
11/09/2023 17:31:40

Needham Maintains Buy on OncoCyte, Lowers ...
11/09/2023 16:43:52

Needham analyst Mike Matson maintains OncoCyte (NASDAQ:OCX) with a Buy and lowers the price target from $4.25 to $3.6.